发明名称 |
Treatment of myelosuppression |
摘要 |
Methods are presented for attenuating myelosuppressive side effects of treatment regimens, promoting thrombopoiesis and neutrophil production, and increasing efficacy of treatment regimens, by administering PF4-interacting heparinoids. |
申请公布号 |
US9271999(B2) |
申请公布日期 |
2016.03.01 |
申请号 |
US201313801990 |
申请日期 |
2013.03.13 |
申请人 |
Cantex Pharmaceuticals, Inc. |
发明人 |
Marcus Stephen |
分类号 |
A61K31/727;A61K35/28;A61K39/395;A61N5/00;A61K45/06 |
主分类号 |
A61K31/727 |
代理机构 |
Fenwick & West LLP |
代理人 |
Fenwick & West LLP |
主权项 |
1. A method of treating thrombocytopenia other than heparin-induced thrombocytopenia, comprising:
administering a substantially non-anticoagulating PF4-interacting heparinoid to a subject with thrombocytopenia other than heparin-induced thrombocytopenia in an amount effective to promote thrombopoiesis. |
地址 |
Weston FL US |